Brazil Biosimilars Databook 2023: Product, Type of Cell, Imaging Technique, Procedure, Source of Manufacturing, Applications, Type of Technology, and End Users 2018-2027
May 08, 2023 08:23 ET
|
Research and Markets
Dublin, May 08, 2023 (GLOBE NEWSWIRE) -- The "Brazil Biosimilars Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ResearchAndMarkets.com's offering. ...
Japan Biosimilars Business and Investment Opportunities Report 2023: Market Size is Expected to Record a CAGR of 29.2% During 2023-2027 to Reach US$3,203.6 Million by 2027
May 05, 2023 10:13 ET
|
Research and Markets
Dublin, May 05, 2023 (GLOBE NEWSWIRE) -- The "Japan Biosimilars Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ResearchAndMarkets.com's offering. ...
South Korea Biosimilars Business and Investment Opportunities Report 2023
May 05, 2023 10:03 ET
|
Research and Markets
Dublin, May 05, 2023 (GLOBE NEWSWIRE) -- The "South Korea Biosimilars Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ResearchAndMarkets.com's offering. ...
Canada Biosimilars Business and Investment Opportunities Databook, 2018-2022 & 2023-2027
May 05, 2023 09:38 ET
|
Research and Markets
Dublin, May 05, 2023 (GLOBE NEWSWIRE) -- The "Canada Biosimilars Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ResearchAndMarkets.com's offering. ...
Global Filgrastim Biosimilars Market Research Report 2023: Focus on Zarxio, Nivestym, and Releuko
May 02, 2023 06:03 ET
|
Research and Markets
Dublin, May 02, 2023 (GLOBE NEWSWIRE) -- The "Filgrastim Biosimilars Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global filgrastim biosimilars market...
Oral Biologics & Biosimilars Global Market Report 2023: Creation of an Insulin Biosimilar Presents Lucrative Opportunities
April 20, 2023 08:18 ET
|
Research and Markets
Dublin, April 20, 2023 (GLOBE NEWSWIRE) -- The "Oral Biologics & Biosimilars Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global oral biologics...
Global Biosimilars Business and Investment Opportunities 2023: Sector to Reach $42.3 Billion by 2026 at a 22% CAGR
April 18, 2023 05:58 ET
|
Research and Markets
Dublin, April 18, 2023 (GLOBE NEWSWIRE) -- The "Global Biosimilars Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals,...
Biosimilar Contract Manufacturing Global Market Report 2023: Increasing Demand for Contract Research Organizations Drives Growth
April 11, 2023 07:03 ET
|
Research and Markets
Dublin, April 11, 2023 (GLOBE NEWSWIRE) -- The "Biosimilar Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Product...
The Worldwide Biosimilars Industry is Expected to Reach $47.4 Billion by 2027: Patent Expiration of Well-Known Biologics Drives Growth
February 10, 2023 11:03 ET
|
Research and Markets
Dublin, Feb. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Biosimilars Market Size, Trends and Growth Opportunity, By Product, By Indication, By Region and Forecast to 2027." report has been added to ...
Biosimilar Contract Manufacturing Global Market Report 2022: Favorable Policies Encouraging Use of Biosimilars Present Opportunities
January 12, 2023 07:23 ET
|
Research and Markets
Dublin, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The "Biosimilar Contract Manufacturing Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.The...